Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance
March 01, 2017 07:00 ET
|
Akorn, Inc.
- Q4 2016 Revenue Increase to $284 Million - - Q4 2016 GAAP Diluted EPS Decrease of 4% to $0.26; Q4 2016 Adjusted Diluted EPS Decrease of 3% to $0.58 - - FY 2016 Revenue Increase of 13% to $1,117...
Akorn Receives Approval for Mycophenolate Mofetil for Injection, USP
February 28, 2017 17:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug...
Akorn to Report Fourth Quarter and Full Year 2016 Results
February 06, 2017 07:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on...
Akorn to Present at 35th Annual J.P Morgan Healthcare Conference
December 21, 2016 07:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn’s CEO, Raj Rai, will present at the...
Akorn Announces Completion of FDA Re-inspection of Decatur Facility
December 12, 2016 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) conducted...
Akorn Launches Ibuprofen Oral Suspension
November 29, 2016 07:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the prescription version of Ibuprofen...
Akorn Invalidates Durezol® Patent Via Inter Partes Review Proceeding
November 28, 2016 17:15 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that on November 22, 2016, the Patent Trial and Appeal...
Akorn to Present at Piper Jaffray 28th Annual Healthcare Conference
November 16, 2016 08:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn’s Chief Financial Officer, Duane...
Akorn Provides Third Quarter 2016 Results
November 03, 2016 07:05 ET
|
Akorn, Inc.
- Q3 2016 Revenue Increase of 11% to $284 million - - Q3 2016 GAAP EPS of $0.38; Adjusted Q3 2016 EPS of $0.56 - - Updates 2016 Revenue, EPS and Adjusted EBITDA Guidance - - Repurchased $25 Million...
Akorn Announces Third Quarter 2016 Earnings Release and Conference Call Information
October 13, 2016 08:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on...